Global S-Adenosyl Methionine Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global S-Adenosyl Methionine Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

S-Adenosyl Methionine is a compound found naturally in the body. S-Adenosyl Methionine helps produce and regulate hormones and maintain cell membranes.

A synthetic version of S-Adenosyl Methionine is available as a dietary supplement in the U.S. In some countries in Europe, S-Adenosyl Methionine is a prescription drug.

S-Adenosyl Methionine can be taken orally, through a muscular injection or by IV. People generally use S-Adenosyl Methionine to treat depression, osteoarthritis and liver disease. However, S-Adenosyl Methionine can also interact with antidepressant medications.

Market Overview:

The latest research study on the global S-Adenosyl Methionine market finds that the global S-Adenosyl Methionine market reached a value of USD 24.43 million in 2022. It’s expected that the market will achieve USD 35.56 million by 2028, exhibiting a CAGR of 6.46% during the forecast period.

S-Adenosyl Methionine Drivers

S-Adenyl Methionine is an important metabolic intermediate widely existing in organisms. S-Adenosyl Methionine is involved in more than 40 biochemical reactions in vivo, which is closely related to the synthesis of protein, nucleic acids, neurotransmitters, phospholipids and vitamins, and is connected with the transformation of polyamine and glutathione. In Europe, S-Adenosyl Methionine has been widely used as a prescription drug in the treatment of liver diseases, depression, arthritis and other diseases. In America, it has become a popular healthcare product. It also has a certain potential in the treatment of heart disease, schizophrenia, anxiety, tendonitis, chronic back pain, migraine, premenstrual syndrome and chronic fatigue syndrome. With the expansion of S-Adenosyl Methionine's application fields, the market development prospect of products is broad.

S-Adenosyl Methionine Market Challenges

With the increasing demand for S-Adenosyl Methionine, the establishment of cheap and effective S-Adenosyl Methionine production technology is the key to its large-scale popularization and application. Microbial fermentation is the main way to industrially produce S-Adenosyl Methionine since 1960s. In some regions, although the research on S-Adenosyl Methionine preparation method has been carried out for decades, it has not been industrialized due to low technical level and high cost. At present, there are relatively few manufacturers in the market that can carry out large-scale production, and the product price is relatively high, which limits the popularization of products in more markets.

S-Adenosyl Methionine Market Restraints

S-Adenosyl Methionine is mainly used as medicine or dietary supplement. S-Adenosyl Methionine has been used as a dietary supplement in the United States, but it is used as a prescription drug in Italy, Spain and Germany. Therefore, S-Adenosyl Methionine products are strictly supervised by food and drug regulatory authorities. The medical use of S-Adenosyl Methionine in America has not been approved by FDA. The sales of S-Adenosyl Methionine products in various regions are strictly regulated by FDA, EMA, SFDA and other departments.

Region Overview:

From 2022-2027, North America is estimated to witness robust growth prospects.

Company Overview:

Lesaffre, BOC Sciences, Zhejiang Hisun Pharmaceutical Co,Ltd., Kono Chemical, and Meteoric Biopharmaceuticals are the five key players in the global S-Adenosyl Methionine market. These companies have shown consistent growth in revenue, larger volumes of sales, and a prominent presence in terms of share in the global S-Adenosyl Methionine market in the past 5 years.

The Lesaffre Group is the world leader in yeast, yeast extracts, and baking ingredients, with an industrial presence in more than 50 countries and 10,000 employees throughout the world. The Lesaffre Group has been family-owned since 1853 and is headquartered in Lille, France.

Gnosis Bioresearch is expert in biotransformation processes like fermentation and Gnosis Bioresearch cultivates actives ingredients, probiotics, and nutritional and functional yeasts that benefit human health and wellbeing. Gnosis Bioresearch collaborates with pharmaceutical and nutraceutical brands and industries, including dietary supplements and functional foods&beverages, to develop game-changing products. Gnosis Bioresearch harnesses the power of microorganisms to produce bioactive ingredients, such as Vitamin K2, SAMe, Active Folate, S.boulardii and moreover to improve human health.

BOC Sciences provides a wide variety of custom services which range from bulk compounds to specialty species in the pharmaceutical, agrochemical, and biotechnology industries. BOC Sciences are committed to providing our customers with the best products and services at the most competitive prices.

Segmentation Overview:

Among different product types, Purity<=99% segment is anticipated to contribute the largest market share in 2027.

Application Overview:

By application, the Health Care segment occupied the biggest share from 2017 to 2022.

Key Companies in the global S-Adenosyl Methionine market covered in Chapter 3:

Biosynth Carbosynth
Meteoric Biopharmaceuticals
Lesaffre
BOC Sciences
Zhejiang Hisun Pharmaceutical Co ,Ltd.
Kono Chemical

In Chapter 4 and Chapter 14.2, on the basis of types, the S-Adenosyl Methionine market from 2018 to 2029 is primarily split into:

Purity<=99%
Purity >99%

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the S-Adenosyl Methionine market from 2018 to 2029 covers:

Health Care
Pharmaceutical
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)